ViewPoint Therapeutics' Series A Round

ViewPoint Therapeutics raised a round of funding on May 02, 2016.

ViewPoint Therapeutics is a biotechnology company dedicated to the development of treatments for diseases of protein misfolding, including cataracts.…

Articles about ViewPoint Therapeutics' Series A Round: